| Autor: |
Gorbounova VA; N. N. Blokhin Russian Cancer Research Center, Moscow, Russia., Bychkov MB; N. N. Blokhin Russian Cancer Research Center, Moscow, Russia., Vladimirova LY; Rostov Scientific Research Oncological Institute, Rostov-on-Don, Russia., Levchenko EV; N. N. Petrov Research Oncology Institute, Saint-Petersburg, Russia., Karpenko TD; N. N. Blokhin Russian Cancer Research Center, Moscow, Russia., Mamontov OY; N. N. Petrov Research Oncology Institute, Saint-Petersburg, Russia., Burmistrov V; Eli Lilly Vostok S. A., Moscow, Russia., Novick D; Eli Lilly Holdings Limited, Windlesham, UK., Rajan N; Eli Lilly Australia Pty Ltd, West Ryde, NSW, Australia., Sholokhova E; Eli Lilly Vostok S. A., Moscow, Russia., Solovyenko Y; Eli Lilly Vostok S. A., Moscow, Russia., Tjulandin SA; N. N. Blokhin Russian Cancer Research Center, Moscow, Russia. |
Full Text from ScienceDirect